Bilgic, Alper
Kodjikian, Laurent
de Ribot, Francesc March
Spitzer, Martin S.
Vasavada, Vaishali
Gonzalez-Cortes, Jesus Hernan
Sudhalkar, Aditya
Chakraborty, Somnath
Mathis, Thibaud
Article History
Received: 18 September 2023
Revised: 5 November 2023
Accepted: 23 November 2023
First Online: 8 December 2023
Declarations
:
: This study complied with the tenets of the Declaration of Helsinski and was approved by an international review board (Ethics Committee of the French Society of Ophthalmology, IRB 00008855 Société Française d’Ophtalmologie IRB#1). Patients gave their informed consent to participate in the study.
: Informed consent was obtained from all subjects involved in the study.
: Laurent Kodjikian is consultant for Allergan/Abbvie, Bayer, Horus, Novartis, Roche, and Théa. Martin S Spitzer is consultant for Apellis, Abbvie, Bayer, Neurogene, and Roche. Thibaud Mathis is consultant for Allergan/Abbvie, Bayer, GSK, Horus, and Novartis. Other authors have no conflict of interest to declare.